Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Sebela Pharmaceuticals clinical trials
The registry lists 56 studies whose lead sponsor is Sebela Pharmaceuticals or one of 3 companies grouped under it. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Keep track of what changes. Save the Sebela Pharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sebela Pharmaceuticals.
- Braintree Laboratories49 studies →Acquired — became part of Sebela Pharmaceuticals, May 1, 2018 · source ↗
Something wrong?
- Sebela Women's Health Inc.6 studies →Subsidiary
Something wrong?
- Sebela Pharmaceuticals Development LLC1 study →Subsidiary
Something wrong?
Focus areas
Conditions Sebela Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 56. Browse all 56 →
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptNot yet recruitingNCT04457076Phase 3
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux DiseaseCompletedNCT05587322Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisCompletedNCT05587309Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation of the Efficacy and Safety of LevoCeptCompletedNCT02882191Phase 2
Sponsor listed in the registry: Sebela Women's Health Inc.
- Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible ContraceptionCompletedNCT02446821Phase 2
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseCompletedNCT05890001Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation of Efficacy, Safety and Tolerability of VeraCept IUSActive, not recruitingNCT03633799Phase 3
Sponsor listed in the registry: Sebela Women's Health Inc.
- A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)CompletedNCT03785366Phase 3
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Safety Study of 3 Different Bowel Cleansing PreparationsCompletedNCT01501513Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult SubjectsCompletedNCT03103581Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of BLI4700 Bowel Preparation in Adult SubjectsCompletedNCT03023085Phase 1/2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's DiseaseTerminatedNCT01442363Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic ConstipationCompletedNCT02822508Phase 2/3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT04446299Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT04446312Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of BLI4900 Bowel Preparation in Adult SubjectsCompletedNCT03328507Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open-Label Preference Evaluation of BLI800CompletedNCT04214301Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUDCompletedNCT02167763Phase 1
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT03261960Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to ColonoscopyCompletedNCT03404401Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing ColonoscopyCompletedNCT02819323Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing ColonoscopyCompletedNCT02189850Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsCompletedNCT02481947Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsCompletedNCT02819297Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study of Chronic Use of BLI400 Laxative in Constipated AdultsCompletedNCT02819310Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent SubjectsCompletedNCT02665728Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic ConstipationCompletedNCT02820714Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Safety and Efficacy Study of an Edible Colonoscopy PreparationCompletedNCT03332485Phase 2
Sponsor listed in the registry: Sebela Pharmaceuticals Development LLC
- A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne VulgarisCompletedNCT02604680Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing ColonoscopyCompletedNCT02376465Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01815450Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT01786629Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated AdultsCompletedNCT01687985Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00756548Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00756977Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating MedicationsCompletedNCT00153127Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- PolyethyleneGlycol3350 Laxative vs Placebo in Constipated ChildrenCompletedNCT00153114Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic ConstipationCompletedNCT00153140Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated PatientsCompletedNCT00164125Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated ChildrenCompletedNCT00319670Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- HalfLytely Bowel Prep System for ColonoscopyCompletedNCT00164164Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Extended Use of Polyethyleneglycol3350 Laxative in Constipated PatientsCompletedNCT00153153Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.CompletedNCT00164151Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.CompletedNCT00164177Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI1100 for the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01241331Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI801 Laxative in Constipated AdultsCompletedNCT01301781Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry ParametersCompletedNCT00583713Phase 1/2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00856843Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00857272Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)CompletedNCT00373334Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals